Mike Pompeo switches his critical role from CIA Director to State Secretary in a secret visit to North Korea.

Peter Prince

2018-04-13 14:42:00 Fri ET

Mike Pompeo switches his critical role from CIA Director to State Secretary in a secret visit to North Korea with no regime change as the North Korean dictator Kim Jong-Un intends to end the 65-year Korean War. Major U.S. and East Asian stock markets experience healthy gains in response to this positive result.

Pompeo is now the most senior U.S. diplomat who directly meets and approaches Kim. This secret visit signals the fact that President Trump sends goodwill to the North Korean leader prior to their bilateral peace summit. The recent core dialogue between Kim and Pompeo upholds the genuine belief that Trump can engage in productive negotiations with North Korea over its intercontinental ballistic missile programs. Trump-Kim direct talks help strengthen the plausible case for peace and denuclearization on the Korean peninsula in the next decade.

Pompeo remains optimistic about a Trump-Kim peace summit during his Senate confirmation testimony for his fresh post of State Secretary. At this stage, Pompeo expects the peace summit to happen for a positive diplomatic outcome with North Korea. This summit serves as an incremental step toward Korean denuclearization, and the current dialogue helps alleviate the current nuclear threat from North Korea. The Trump team plans to continue the current U.N.-driven economic sanctions on North Korea until its complete and comprehensive denuclearization.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

Netflix has an unsustainable business model in the meantime.

Becky Berkman

2019-05-02 13:30:00 Thursday ET

Netflix has an unsustainable business model in the meantime.

Netflix has an unsustainable business model in the meantime. Netflix maintains a small premium membership fee of $9-$14 per month for its unique collection

+See More

IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment.

Charlene Vos

2019-04-29 08:35:00 Monday ET

IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment.

IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment. First, trade tensions remain one of the key

+See More

North Korean leader and president Kim Jong-Un seeks peaceful resolution and denuclearization on the Korean Peninsula.

Olivia London

2018-04-11 09:37:00 Wednesday ET

North Korean leader and president Kim Jong-Un seeks peaceful resolution and denuclearization on the Korean Peninsula.

North Korean leader and president Kim Jong-Un seeks peaceful resolution and denuclearization on the Korean Peninsula. When *peace* comes to shove, Asia

+See More

Empirical tests of multi-factor models for asset return prediction

Apple Boston

2022-02-25 00:00:00 Friday ET

Empirical tests of multi-factor models for asset return prediction

Empirical tests of multi-factor models for asset return prediction  The capital asset pricing model (CAPM) of Sharpe (1964), Lintner (1965), and Bla

+See More

Facebook faces a major data breach by Cambridge Analytica that has harvested information from 50 million Facebook users.

Amy Hamilton

2018-03-17 09:35:00 Saturday ET

Facebook faces a major data breach by Cambridge Analytica that has harvested information from 50 million Facebook users.

Facebook faces a major data breach by Cambridge Analytica that has harvested private information from more than 50 million Facebook users. In a Facebook pos

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More